Treatment of Chronic Hepatitis C in Special Populations
© 2015 Elsevier Inc. The management of hepatitis C virus (HCV) infection in special populations is challenging. The efficacy and safety data of the currently approved all-oral direct-acting antiviral combinations, including sofosbuvir, ledipasvir, daclatasvir, paritaprevir/ritonavir/ombitasvir plus...
Saved in:
Main Authors: | Chalermrat Bunchorntavakul, Tawesak Tanwandee |
---|---|
Other Authors: | Rangsit University |
Format: | Review |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/36234 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Hepatitis c genotype 6: A concise review and response-guided therapy proposal
by: Chalermrat Bunchorntavakul, et al.
Published: (2018) -
Efficacy of pegylated interferon and ribavirin for the treatment of chronic hepatitis C, genotype 3 patients in Thailand
by: Watcharasak Chotiyaputta, et al.
Published: (2019) -
Long-term outcomes of chronic hepatitis C patients with sustained virological response at 6 months after the end of treatment
by: Disaya Chavalitdhamrong, et al.
Published: (2018) -
Pathologically different features and fibrosis scores in chronic hepatitis C genotypes 3 and 1
by: Ananya Manuyakorn, et al.
Published: (2018) -
Treatment outcomes and validation of the stopping rule for response to peginterferon in chronic hepatitis B: A Thai nationwide cohort study
by: Phunchai Charatcharoenwitthaya, et al.
Published: (2018)